| Literature DB >> 35458730 |
Aušra Adomėnienė1, Petras Rimantas Venskutonis1.
Abstract
Dioscorea, consisting of over 600 species, is the most important genus in the Dioscoreaceae family; however, the practically used plants, which are commonly called yam, are restricted to a remarkably smaller number of species. Numerous studies have reported the high nutritional value of yam, particularly as an alternative source of starch and some important micronutrients. Several Dioscorea species are widely used for various medicinal purposes as well. In many studies, the bioactivities and health benefits of Dioscorea extracts and other preparations have been related to the presence of phytochemicals, which possess antioxidant properties; they are related mainly to radical-scavenging capacity in chemical assays and positive effects on the endogenous antioxidant system in cell-based and in vivo assays. Considering the increasing number of publications on this topic and the absence of comprehensive and focused review papers on antioxidant potential, this article summarizes the results of studies on the antioxidant properties of Dioscorea spp. and their relation to phytochemicals and health benefits. A comprehensive survey of the published articles has revealed that the majority of studies have been performed with plant tubers (rhizomes, roots), while reports on leaves are rather scarce. In general, leaf extracts demonstrated stronger antioxidant potential than tuber preparations. This may be related to the differences in phytochemical composition: saponins, phenanthrenes and, for some pigment-rich species (purple yams), anthocyanins are important constituents in tubers, while phenolic acids and flavonoids are characteristic phytochemicals in the leaves. The review may assist in explaining ethnopharmacological knowledge on the health benefits of Dioscorea plants and their preparations; moreover, it may foster further studies of poorly investigated species, as well as their wider application in developing new functional foods and nutraceuticals.Entities:
Keywords: Dioscorea; antioxidant potential; phytochemicals; radical-scavenging capacity
Mesh:
Substances:
Year: 2022 PMID: 35458730 PMCID: PMC9026138 DOI: 10.3390/molecules27082530
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.927
Search results for available publications on Dioscorea (accessed on 21 December 2021).
| Search Words | WoS | Science Direct | PubMed | |||
|---|---|---|---|---|---|---|
| Total | Review | Total | Review | Total | Review | |
| 4779 | 218 | 5171 | 553 | 1665 | 61 | |
| 2152 | 24 | 508 | 2 | 937 | 16 | |
| 509 | 26 | 257 | 41 | 203 | 12 | |
| 237 | 7 | 109 | 2 | 108 | 1 | |
| 73 | 1 | na * | na | 0 | 0 | |
* na, not applicable.
Antioxidant characteristics of various Dioscorea spp.
| Species: Plant Part | Solvent, Analyzed Product | Antioxidant Characteristics | Ref. |
|---|---|---|---|
| MeOH-E | DPPH• (IC50, µg/mL): 142.30 ± 2.58 | [ | |
| EtOH (80%)-E | DPPH• (IC50, mg/gm dw): 0.603 ± 0.010 | [ | |
| H2O 1:10 ( | DPPH• (IC50, mg/mL): 18.52 ± 2.1/17.86 ± 0.9 | [ | |
| Effect of processing | DPPH• (%): 79.08 (raw), 61.75 (blanched), 40.75 (washed), 32.16 (dried), 30.01 (flour) | [ | |
| H2O + AcA (5%)-E | DPPH• (EC50, mg/mL): 2.55 to 8.70, depending on origin and treatment | [ | |
| MeOH-E | DPPH• (IC50, μg/mL): 14.68 (AA 24.95) | [ | |
| Yam flour | ORAC (μmol TE/g): | [ | |
| EtOH (80%)-E: flesh/peel | DPPH• (IC50, µg de/mL): 183.4 ± 5.3/47.7 ± 2.7; | [ | |
| EA fr: flesh/peel | DPPH•: 13.9 ± 1.1/8.5 ± 0.2; FRAP: 630.1 ± 19.4/534.4 ± 35.3 | ||
| BuOH fr: flesh/peel | DPPH•: 245.1 ± 32.1/43.8 ± 3.3; FRAP: 83.9 ± 5.3/162.1 ± 3.0; ABTS•+: 111.8 ± 5.5/448.4 ± 9.0; •O2−: 333.2 ± 10.6/147.9 ± 4.1 | ||
| HX fr: flesh/peel | DPPH•: 632.0 ± 26.9/55.0 ± 0.9; FRAP: 42.3 ± 1.2/97.3 ± 11.2; ABTS•+: 39.8 ± 1.6/242.3 ± 14.4; •O2−: 1387.5 ± 110.3/237.9 ± 12.2; ChelA: 32.0 ± 2.2/34.1 ± 1.2 | ||
| Remaining H2O fr: flesh/peel | DPPH•: 1532.7 ± 123/225.1 ± 12.9; FRAP: 8.5 ± 0.5/29.1 ± 1.7; ABTS•+: 12.2 ± 0.3/74.0 ± 2.9; •O2−: 874.5 ± 18.2/461.1 ± 14.1 | ||
| Hot pressurized EtOH-E: flesh/peel | DPPH• (EC50, µg/mL): ND/86.6–305.4 | [ | |
| fr of HX/CF/EA/BuOH/H2O | Flesh: 328–2360/144.6–549.4/112.8–343.6/288.1–1526/ND | ||
| EtOH (95%)-E flesh/peel | DPPH• (IC50, mg/mL): 7.68/0.944 | [ | |
| 2,7-dOH-4,6-dMetOP/6,7-dOH -2,4-dMetOP/6-OH-2,4,7-tMetOP | DPPH• (IC50, mg/mL): 0.0645/0.154/0.566 | ||
| EtOH (70%)/MeOH (70%)/CF: MeOH (2:1) | DPPH• (IC50, mg/mL): 1.22 ± 0.03/1.34 ± 0.02/0.71 ± 0.00 | [ | |
| EtOH (70%)/MeOH (70%)/CF: MeOH (2:1) | Fe2+ chelating: 0.12 ± 0.02/0.09 ± 0.01/0.97 ± 0.03 | [ | |
| BuOH/EA | ABTS•+ (IC50, mg/mL): 0.70 ± 0.01/0.45 ± 0.01 | [ | |
| BuOH/EA | Fe2+ chelating: 0.64 ± 0.01/0.70 ± 0.01 | [ | |
| BuOH/EA | ABTS•+ (IC50, mg/mL) 1.31 ± 0.05/0.98 ± 0.02 | [ | |
| BuOH/EA | Fe2+ chelating: 0.11 ± 0.02/0.81 ± 0.01 | [ | |
| EtOH (95%) extract | (EC50, μg/mL) DPPH•, 8.53 ± 1.32; ABTS•+, 21.56 ± 1.72; •O2−, 50.91 ± 0.39; •NO, 26.93 ± 4.79; LPI: 33.37 ± 2.88. | [ | |
| MeOH (80%) | DPPH• (IC50, μg/mL): 261.09; AA, 10.65; •O2−, 2089.3; Q, 17.01 | [ | |
| EtOH/H2O crude extracts | DPPH• (IC50, μM): 34.14 ± 0.68/13.20 ± 0.77 | [ | |
| CF/EA/H2O fr of EtOH | DPPH•: 13.35 ± 0.37/14.00 ± 0.36/18.83 ± 0.46 | ||
| MeOH/EA/HX extracts | DPPH• (%): 79.0 ± 0.31/23.2 ± 0.05/11.5 ± 0.31 | [ | |
| PE/EA/MeOH (sequentially)/EtOH (70%) | DPPH• (%): 61.82 ± 1.55/82.79 ± 1.24/76.11 ± 1.26/80.64 ± 1.24 | [ | |
| Pre-purified/crude polysaccharide | DPPH• (mg IE/g): 0.28 ± 0.01/0.94 ± 0.02 | [ | |
| Pre-soaking in 0–10% oligosaccharide | DPPH• (0.1 mL): ~17–27% | [ | |
| Successively DCM/EA/MeOH | DPPH• (IC50, μg/mL): 49.7 ± 0.97/11.9 ± 0.85/11.8 ± 0.23 | [ | |
|
| 89.0 ± 5.10/103.2 ± 6.9/137 ± 5.90 | ||
| 46.7 ± 1.57/14.6 ± 0.90/29.9 ± 0.68 | |||
| 57.7 ± 1.32/64.1 ± 0.89/68.6 ± 8.50 (AA, 6.90; GA, 8.60) | |||
| EtOH (70%) | DPPH• (mg TE/g edw): 279 ± 4 | [ | |
| DE/EA crude extracts | DPPH•: 8.7 ± 0.9/40.1 ± 0.2; ABTS•+, 7.6 ± 0.0/11.6 ± 0.0; FRAP, 44.8 ± 3.6/79.0 ± 0.0; CUPRAC, 10.01 ± 0.2/20.8 ± 0.5 (all IC50, µg/mL) | [ | |
| 3 purified phenanthrenes | DPPH•, <200/61.2 ± 1.1/6.0 ± 0.2; ABTS•+, <200/19.60 ± 0.0/2.4 ± 0.1; FRAP, <50/<50/9.9 ± 1.0; CUPRAC, <200/194.0 ± 0/15.0 ± 0.5 (all IC50, µg/mL) | ||
| H2O/MeOH/EA-E | ORAC (µmol TE/g): ~33/63/48 (white); ~29/96/73 (yellow) | [ | |
| MeOH-Amberlite XAD-7-Sep-Pak C18 | •OH scavenging (IC50 mg/mL): 0.098 ± 0.032 (AA, 1.21 ± 0.0) | [ | |
| MeOH-E | Fe3+ RP (mg AAE/g): 3.30 at 0.5 g/mL | [ | |
| MeOH-E | Fe3+ RP (mg AAE/g): 4.71 at 0.5 g/mL | [ | |
| EtOH (70%)-E | DPPH• (%, 0.5 mL): 43.2 ± 2.35; ABTS•+ (%, 20 μL): 40.01 ± 3.0; SOD (%, 0.2 mL): 39.97 ± 8.87 | [ | |
| Cold/warm/hot H2O extracted polysaccharides | DPPH• (IC50, mg/mL): 4.56 ± 0.15/6.95 ± 0.13/8.85 ± 0.16 | [ | |
| MeOH-E | DPPH• (µg/mL): 371.64 ± 12.30 | [ | |
| H2O-soluble polysaccharide | •OH scavenging (%): 3.35–43.73 at 0.25–4 mg | [ | |
| EtOH (70%)-E | (mg TE/g edw) DPPH•: 415 ± 9; ABTS•+: 659 ± 4 | [ | |
| Hot H2O-E | DPPH• (IC50, μg/mL): 1008.62 ± 5.96/374.85 ± 6.78 | [ | |
| EtOH (80%)-E | DPPH• (IC50, μg/mL): 897.14 ± 4.73/415.74 ± 3.79 | ||
| EA (80%)/MeOH | DPPH• (IC50, μg/mL): 135.12 ± 0.95/85.61 ± 0.64 | [ | |
| MeOH/Ac crude extracts | DPPH• (EC50, μg/mL): 82.07 ± 0.08/89.41 ± 0.39 | [ | |
| EtOH (70%) | DPPH•: at 0.1–10 mg/mL from 18.01 to 89.64% | [ | |
| H2O/MeOH-E | DPPH• (IC50 μg edw/mL): 21.36/40.24 | [ | |
| H2O 1:10 ( | DPPH• (IC50, mg/mL): 19.26 ± 2.4/19.56 ± 1.5 | [ | |
| 18 compounds from MeOH-E | DPPH• (EC50, µg/mL): 12.3 ± 0.2->100 (AA = 19.2) | [ | |
| H2O-E | (%) DPPH• 38.2 ± 3.14/•O2−, 84.1 ± 6.57/•OH, 79.4 ± 6.42; | [ | |
|
| MeOH (60%) | ABTS•+ (MTE/100 gMF): 0.153 (yellow); 0.218 (with red dot); 0.151 (red fleshed) | [ |
|
| EtOH (70%) | DPPH• (%): 64.81 ± 2.80; ABTS (%): 72.44 ± 5.28 | [ |
|
| DPPH• (%): 77.09 ± 0.00; ABTS (%): 99.89 ± 1.60 | ||
|
| DPPH• (%): 75.74 ± 0.94; ABTS (%): 83.66 ± 9.03 | ||
|
| DPPH• (%): 84.46 ± 0.41; ABTS (%): 95.56 ± 0.96 | ||
| MeOH (70%)/EtOH (70%)/CF: MeOH (2:1) | DPPH• (IC50, mg/mL): 0.56/0.52/0.43 | [ | |
| Autolysis/hydrolysis (pepsin/trypsin/papain) | •O2- (all in % at 100 mg/mL): 60.2 ± 4.01/82.2 ± 5.95 (p)/56.0 ± 4.36 (t)/98.5 ± 3.54 (p)/52.6 ± 4.18 | [ | |
| MeOH-E and fractions/HX/EA/BuOH/H2O | DPPH• (IC50, µg/mL): 602.2 ± 71.92/510.6 ± 25.02/80.5 ± 12.37/263.0 ± 56.47/>1000 | [ | |
| Arial bulbils | MeOH-E and fractions/HX/EA/BuOH/H2O | DPPH• (IC50, µg/mL): 376.3 ± 32.18/180.9 ± 24.77/38.1 ± 5.82/161.4 ± 32.14/>1000 | [ |
| EtOH (50%)/hot H2O/H2O | DPPH• (mg α-Toc eq/g): 4.14 ± 0.01/3.71 ± 0.03/3.37 ± 0.04 (peel); 0.73 ± 0.07/0.72 ± 0.03/0.22 ± 0.03 (flesh) | [ | |
| MeOH (80%)-E: CF/EA/BuOH/H2O Fr/AA | DPPH• (µg): 200.8 ± 7.9: 38.8 ± 3.6/14.8 ± 0.6/75.4 ± 1.6/>1000/3.3 | [ | |
| DPPH• (µg): 84.0 ± 2.6: 23.6 ± 2.0/9.2 ± 0.2/27.6 ± 0.8/>1000/3.3 | |||
| ABTS•+ (µmol TE/100 g): 131.14 ± 5.49 to 174.52 ± 0.78 (depending on drying method) | [ | ||
| (IC50, mg/mL) DPPH•: 7.44; ABTS•+: 0.54; •O2−: 13.67 | [ |
Abbreviations: AA—ascorbic acid; AAE—ascorbic acid equivalent; Ac—acetone; ABTS•+—2,2′-azinobis-(3-ethylbenzothiazoline-6-sulfonate) scavenging capacity; AcA—acetic acid; AAE—ascorbic acid equivalent; BHT—butyl hydroxy toluene; BuOH—n-butanol; CF—chloroform; ChelA—chelating activity; CUPRAC—cupric reducing antioxidant capacity; DCM—dichloromethane; de—dried extract; DE—diethyl ether; DPPH•—(2,2-diphenyl-1-picrylhydrazyl) scavenging capacity; dw—dry weight; E—extract; EA—ethyl acetate; edw—extract dry weight; eq—equivalent; EtOH—ethanol; Fe2+,Fe3+—ferric ion; fr—fraction; FRAP—ferric reducing antioxidant power (determined using ferric-tripyridyltriazine complex); Fe3+ RP—ferric reducing power (determined using potassium ferricyanide complex); GA—gallic acid; GAE—gallic acid equivalents; H2O—water; HX—hexane; IC50—effective concentration reducing 50% of the radicals present in the reaction; LPI—lipid peroxidation inhibition; MeOH—methanol; ND—not detected; NO2—nitrogen dioxide radical; •NO—nitric oxide scavenging activity; •O2−—superoxide anion scavenging activity; O2−—superoxide radical-scavenging activity; •OH—hydroxyl radical-scavenging activity; ORAC—oxygen radical absorbance capacity; pdw—plant dry weight; PE—petrol ether; Q—quercetin; SOD—superoxide dismutase; TE—Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid) equivalent; α-Toc—α-tocopherol; 2,7-dOH-4,6-dMetOP—2,7-dihydroxy-4,6-dimethoxy phenanthrene; 6,7-dOH-2,4-dMetOP—6,7-dihydroxy-2,4-dimethoxy phenanthrene; 6-OH-2,4,7-tMetOP—6-hydroxy-2,4,7-trimethoxyphenanthrene (See Supplementary Materials abbreviations).
Total content of various groups of compounds in Dioscorea spp.
| Species: Plant Part | Solvents | Characteritics | Ref. |
|---|---|---|---|
| MeOH | TPC: male 12.21 ± 0.82; female: 17.53 ± 1.30 | [ | |
| EtOH (20%) fr. | TS (%): male: 0.48 ± 0.06; female: 0.93 ± 0.17 | ||
| H2O + AcA (5%): in H2O/NaHSO3 0.2%)/AA (0.1%) | TPC: 11.6 ± 0.31/12.7 ± 0.67/11.5 ± 0.13 | [ | |
| H2O | TPC: 1.00–3.85; TFC: 0.60–1.60; TAC: 0.10–0.90 | [ | |
| EtOH (50%)/hot H2O/H2O | TPC (peel): 11.14 ± 0.30/6.09 ± 0.08/6.60 ± 0.13 | [ | |
| EtOH (80%) | TPC (mg GAE/g edw): 63.85 ± 1.83; TFC (mg RE/g edw): 8.21 ± 0.02; TFL (mg QE/g edw): 17.23 ± 0.19 | [ | |
| Effect of processing | TAC (mg/100 g): 38.12 (raw), 36.73 (blanched), 32.63 (washed), 29.29 (dried), 27.27 (flour) | [ | |
| TPC (mg/100 g): 335.64 ± 3.92; TFC: 65.73; C: 23.49 ± 0.0413; H2O-soluble B: 0.036 to 4.159 | [ | ||
| MeOH (50%) + 0.1% HCl | TAC: 3.32 mg/g | [ | |
| MeOH (80%) | TPC (mg GAE/g edw): flesh 48.3 ± 4.1; peel 194.8 ± 14.6 | [ | |
| EA fr | TPC (mg GAE/g edw): flesh 479.5 ± 33.1; peel 695.1 ± 35.1 | ||
| MeOH | TPC (mg GAE/g edw): 222.99; TFC (mg QE/g edw): 98.95 | [ | |
| EtOH (70%)/MeOH (70%)/ | TPC (mg CE/g edw): 43.38 ± 0.66/37.62 ± 0.88/67.17 ± 0.12 | [ | |
| TS (mg/g dw): 42.52 ± 1.88 | [ | ||
| BuOH/EA | TPC (mg CE/g edw): 78.68 ± 0.58/111.88 ± 0.66 | [ | |
| BuOH/EA | TPC (mg GE/g): 53.83 ± 1.00/51.63 ± 2.63 | [ | |
| MeOH-E: and fr HX/EA/BuOH/H2O | TPC (mg/g): 60.60: 12.63/27.48/17.18/4.03 | [ | |
| MeOH (70%)/EtOH (70%)/CF:MeOH (2:1) | TPC: 63.63 ± 0.33/69.47 ± 1.00/97.49 ± 0.66 | [ | |
| MeOH: Jang-Ma/Dang-Ma | TPC (mg/g): 34.86 ± 0.15/45.84 ± 0.34; TFC (mg/g): 6.67 ± 0.22/7.33 ± 0.14; Total sugar (mg/g): 281.96 ± 0.08/140.86 ± 0.21 | [ | |
| MeOH: Dungkun-Daema/Jasak-Ma | TPC (mg/g): 87.05 ± 0.0.11/27.98 ± 0.25; TFC (mg/g): 12.67 ± 0.34/7.75 ± 0.23; Total sugar (mg/g): 184.98 ± 0.14/107.61 ± 0.32 | [ | |
| MeOH-E: and fr HX/EA/BuOH/H2O | TPC (mg/g): 5.05: 2.61/48.31/8.49/3.81 | [ | |
| MeOH-E: fr PE/CTC/DCM/H2O | TPC: 160.65 ± 0.18: 280.09 ± 0.54/287.50 ± 0.71/68.98 ± 1.43/22.99 ± 0.54 | [ | |
| MeOH (80%) | TPC (mg GAE/mg edw): 0.243 ± 0.052; nontannins, 0.632 ± 0.048; tannins, 0.259 ± 0.034. | [ | |
| MeOH: Buchae-Ma | TPC (mg/g): 51.11 ± 0.16; TFC (mg/g): 10.33 ± 0.09; total sugar (mg/g): 179.79 ± 0.14 | [ | |
| MeOH: Dungkun-Ma | TPC (mg/g): 52.08 ± 0.24; TFC (mg/g): 13.99 ± 0.11; total sugar (mg/g): 147.67 ± 0.09 | [ | |
| EtOH (95%). | TPC (mg GAE/g e): 170.85 ± 3.02 | [ | |
| EtOH (95%). | TPC (mg GAE/g e): 170.85 ± 3.02 | [ | |
| MeOH | TPC (mg/100 g FW): 67.17 ± 0.12 | [ | |
| Soaked in 0–10% oligosaccharide solution | TPC (mg GAE/g): 1.37 ± 0.3–1.41 ± 0.1 | [ | |
| PE/EA/MeOH (sequentially)/EtOH (70%) | TPC (mg/mL): 49.22 ± 0.80/98.00 ± 1.17/145.4 ± 3.29/85.89 ± 1.16 | [ | |
| MeOH | TPC: male 41.40 ± 2.94; female: 50.70 ± 2.49 | [ | |
| TFC: male: 25.67 ± 0.93; female: 36.67 ± 0.99 | |||
| EtOH (20%) and its fraction | TS (%): male 0.95 ± 0.14; female 1.16 ± 0.18 | ||
| MeOH | TPC (µg/mL GAE): 158.21; TFC (μg/mL CE): 72.3 | [ | |
| Vanillin-CH3COOH and HClO4 mixture 1:5 ( | TS (dioscin equivalents): 257.8 μg/mL | ||
|
| MeOH-E: fr PE/CTC/DCM/H2O | TPC: 160.65 ± 0.18: 280.09 ± 0.54/287.50 ± 0.71/68.98 ± 1.43/22.99 ± 0.54 | [ |
| MeOH | TPC: male: 11.03 ± 0.60; female: 13.65 ± 0.36 | [ | |
| EtOH (20%) and its fraction | TS (%): male: 0.45 ± 0.09; female: 0.81 ± 0.15 | ||
| Autolysis/hydrolysis | TPC (mg/g powder): 6.4 ± 0.08/15.3 ± 1.60 (pepsin)/11.2 ± 1.34 (trypsin)/7.4 ± 0.09 (papain) | [ | |
| MeOH | TPC (mg GAE/gm dw): male: 31.76 ± 0.21; female: 21.83 ± 2.5 | [ | |
| EtOH (20%) and its fraction | TFC (mg CAE/gm): male: 19.68 ± 1; female: 22.17 ± 0.2 | ||
| MeOH-E | TPC (µg/mL GAE): 297.03; TFC (μg/mL CE) 49.6 | [ | |
| Vanillin-CH3COOH and HClO4 mixture 1:5 ( | TS (μg/mL dioscin equivalents): 475.5 | ||
| Hot H2O | TPC: flesh 1.77 ± 0.67; peel:10.97 ± 0.21; TFC (mg rutin/g eq): flesh: 1.03 ± 0.15; peel 1.77 ± 0.07; TC (mg/g): flesh: 324.90 ± 0.82; peel:123.50 ± 0.80 | [ | |
| EtOH (80%) | Flesh: TPC 7.77 ± 0.10; TFC (mg RE/g extract): 1.20 ± 0.10; TC (mg/g extract) 23.63 ± 0.45 | ||
| Peel: TPC: 15.40 ± 0.10; TFC (mg RE/g extract): 2.62 ± 0.15; TC (mg/g extract) 17.60 ± 0.20 | |||
| MeOH | TPC (mgGAE/g): 213.89 ± 3.93; TFC (mg QE/g): 41.5 ± 2.12 | [ | |
| EA | TPC (mgGAE/g): 76.39 ± 3.54; TFC (mg QE/g): 147.5 ± 3.54 | ||
| EtOH (20%) and its fraction; pasta with 60% yam flour | TPC: traditional process, 2.86 ± 0.02; modified process, 5.04 ± 0.03 | [ | |
| MeOH (60%) | TPC (mg/100 g): 10 (yellow); 8 (with red dot); 8 (red fleshed) | [ | |
| Commonly used methods | TPC (mg GAE/100 g): 187.09–513.67 ± 9.49 | [ | |
| EtOH (95%):HCl 85:15 ( | TAC (mg C-3-Glc/100 g): 159.11–281.10 ± 0.01 | ||
| Dry powders | TPC (mg GAE/100 g dw): 166.10 ± 1.52; TFC (mg QE/100 g dw) 27.63 ± 2.69; TT (mg GAL/100 g dw) | [ | |
| MeOH (male/female) | TPC: 10.73 ± 0.25/9.73 ± 0.28 | [ | |
|
| H2O/MeOH/EtOH/ | TPC (mg/g): 10.16/10.48/14.67/9.91 | [ |
| H2O 1:10 ( | TPC (mg GAE/g): 1.56 ± 0.04/1.34 ± 0.02 | [ | |
| TPC (mg GAE/g): 1.38 ± 0.03/1.12 ± 0.02 | |||
| EtOH (70%) | TPC: 35.15 mg GAE/100 g edw | [ | |
| Inoculated with 6 spp. of arbuscular mycorrhizal fungi; | TPC (mg/kg): Tainung 1: 21.3-44.5/39.0-52.7; Tainung 2: 19.8–38.3/43.9–54.5; Ercih: 11.1–16.9/40.4–50.4 | [ | |
| TFC (mg/kg): Tainung 1: 4.1–8.6/9.9–15.1; Tainung 2: 4.4–6.9/9.6-10.4; Ercih: 4.5–5.6/7.8–10.9; Zigyuxieshu: 4.9–6.5/9.3–11.8 | |||
| TAC (flesh/peel, mg/kg): Tainung 1, 2, Ercih: nd; Zigyuxieshu: 0.83–1.08/1.93–2.54; Tainung 5: 0.33–0.76/1.52–2.42 | |||
|
| EtOH (70%) | TPC: 2.23 ± 0.03; TFC (mg RE/g): 1.99 ± 0.17 | [ |
|
| TPC: 3.65 ± 0.11; TFC (mg RE/g): 2.62 ± 0.20 | ||
|
| TPC: 2.25 ± 0.19; TFC (mg RE/g): 1.57 ± 0.06 | ||
|
| TPC: 9.50 ± 0.38; TFC (mg RE/g): 1.30 ± 0.16 | ||
| BuOH/EA | TPC (mg CAE/g-E): 78.68 ± 0.58/111.88 ± 0.66 | [ | |
| Small/medium/large particle size fractions | Phenols (%): 0.27–1.39/0.52–2.82/0.48–2.20 | [ | |
| TPC (mg GAE/100 g): 157.7 ± 7.5; TFC (mg CE/100 g): 190.4 ± 10.9 | [ | ||
| TPC (mg GAE/100 g): 206.4 ± 12.8; TFC (mg CE/100 g): 178.2 ± 8.3 | [ | ||
| TPC (mg GAE/100 g FW): 166 ± 10 | [ | ||
| TPC (mg GAE/100 g FW): 41 ± 5 | |||
| TPC (mg GAE/100 g FW): 15 ± 2 | |||
| TPC (mg GAE/100 g FW): 13 ± 1 | |||
| MeOH (80%): fr CF/EA/BuOH/H2O | TPC: 2.2 ± 0.1: 11.5 ± 0.4/33.9 ± 1.8/3.9 ± 0.1/2.4 ± 0.1 | [ | |
| TPC: 3.9 ± 0.2: 19.6 ± 0.8/39.1 ± 2.2/7.4 ± 0.4/5.8 ± 0.2 | |||
| Successively DCM/EA/MeOH | TPC (mg GAE/g): 0.25 ± 0.01/8.9 ± 0.69/10.1 ± 0.35 | [ | |
|
| TPC (mg GAE/g): 1.75 ± 0.02/0.81 ± 0.003/1.04 ± 0.02 | ||
| TPC (mg GAE/g): 1.91 ± 0.02/14.0 ± 0.41/5.99 ± 0.09 | |||
| TPC (mg GAE/g): 1.0 ± 0.10/12.6 ± 0.34/0.99 ± 0.01 |
Abbreviations: AA—ascorbic acid; AcA—acetic acid; BuOH—n-butanol; C—vitamin C; CE—catechin equivalents; CF—chloroform; CGE—cyanidin glucoside equivalents; C-3-Glc—cianidina-3-galactosıd; CTC—carbon tetrachloride; B—vitamin B; DCM—dichloromethane; dw—dry weight; E—extract; EA—ethyl acetate; edw—extract dry weight; eq—equivalent; EtOH—ethanol; fr—fraction; FW—fresh weight; GAE—gallic acid equivalents; HX—hexane; MeOH—methanol; NaHSO3—Na-bisulfide; pdw—plant dry weight; PE—petrol ether; pfw—plant fresh weight; Q—quercetin; QE—quercetin equivalents; RE—rutin equivalents; TAC—total anthocyanin content; TFC—total flavonoid content; TFL—total flavonol content; TPC—total phenol content; TS—total saponins; TT—total tanin; α-Toc—α-tocopherol.
Bioactivities of Dioscorea species reported by the in vitro cell studies and in vivo animal studies.
| Species | Preparation | Study Design | Results | Ref. |
|---|---|---|---|---|
| H2O-E in plantain and bitter leaf meal | Rat model, 2.0 g dough meal food, consumed within 25 min. | Blood glucose and GI ↓: the potential to be used as functional foods to alleviate postprandial hyperglycemia | [ | |
| MeOH-E | Antimicrobial activity | Effective against the Gram-positive bacteria | [ | |
| Containing antho-cyanins | TNBS-inducted colitis mice; DACNs at 20, 40, and 80 mg/kg for 3 days, intra-rectally | The levels of pro-inflammatory cytokines, TNF-α and IFN-γ ↓. May be applied as a potential food supplement in inflammatory bowel disease (IBD) therapy | [ | |
| MeOH-E | Antibacterial activity using disc diffusion assay | Effective against the bacteria | [ | |
| MeOH (70%)-E | Mice spleen lymphocytes cells | Anti-inflammatory effect by inhibition of the NO and TNF-α expression. | [ | |
| H2O (WSP) | Alloxan-induced hyperglycemic rats; 400 mg/kg bw/day, 4 weeks, orally | Fasting blood glucose gradually decreased | [ | |
| EtOH and H2O | Doxorubicin-induced cardiac damage mice; daily dose 30 mg/mL for 4 weeks; orally | Regulate NF-kB expression at the transcriptional level; cardiac levels of TBARS, ROS, inflammatory factors, the expression of NF-kB, blood pressure ↑; SOD, GPx activity ↑. | [ | |
| EtOH (80%)-E; EA fr of peel and flesh | Methylglyoxal-induced HepG2 cells | Extracts strengthened antioxidant defense system | [ | |
| Antiglycation activity in vitro | Could inhibit the formation of dicarbonyl compounds in a dose-dependent manner. | |||
| EtOH (95%), DDP | LPS-induced RAW 264.7 cell model | 2, 7-dihydroxy-4, 6-dimethoxy phenanthrene suppressed LPS-induced expression of cytosolic iNOS and COX-2. Could exert anti-inflammatory activity by suppressing NF-κB signaling pathway. | [ | |
| H2O | STZ-induced diabetic mice; at 500 or 1000 mg/kg 1/day for 4 weeks | Glucose and leptin, total cholesterol, triglycerides, low-density lipoprotein cholesterol ↓. | [ | |
| Allantoin at 20 or 50 mg/kg/day for 4 weeks; orally | ||||
| EtOH (60% and 95% | EtOH-induced gastric ulcer in mice; a single dose 100 or 200 mg/kg bw, orally | Extracts dissolved in: 5% Tween-80, 10% polyethylene glycol, 10% DMSO, and 10% EtOH saline: inflammatory factors, NO and IL-6, in the serum; COX-2 expression in the gastric tissue ↓ | [ | |
| EtOH (BDB) | Anti-inflammatory activity in LPS-induced RAW 264.7 cells | NO production (dose-dependent); iNOS protein induction; regulates inflammation by inhibiting the COX-2 pathway | [ | |
| H2O-E; powder | STZ-induced diabetic rats; at 2500 or 1000 mg/kg daily doses for 1-month, orally | Fasting blood glucose and HbAlc ↓; the serum antioxidant activities of tGSH, GSH and SOD ↑; lipid malondialdehyde (MDA), oxidized glutathione (GSSG) ↓ | [ | |
| EtOH-E | SNP-induced oxidative stress in liver BNL CL.2 cells | Elevated cell viability in a dose-dependent manner. Can ameliorate oxidative stress | [ | |
| EtOH and H2O-E | Cell culture model; 1–100 μg/mL E | Low cytotoxic effect on the cells | [ | |
| CF, EA, H2O fr | LPS-induced RAW macrophage 264.7 cells | Mild anti-inflammatory activity | ||
| MeOH-E | MCF-7 and MDA-MB-231 breast cancer cells | Cytotoxic effect in cell lines; prompts apoptosis at various stages and a significant decrease in viable cells | [ | |
| Protein conc. 64% | Antibacterial activity | No inhibition of | [ | |
| MeOH-E | Antimicrobial activity | Effective against | [ | |
| MeOH-E | Xylene-induced ear edema damage mice; 2 and 6 g/kg, 5 days, orally | Decreased the level the inflammatory cytokines and reduced oxidative stress | [ | |
| Warm and hot H2O | Anti-hyperglycemic activity | Effectively inhibits α-amylase, α-glucosidase | [ | |
|
| EtOH-E | λ-carrageenan-induced paw edema mice; 0.5 and 1.0 g/kg, orally | MDA, NO, TNF-α ↓ after 5th hour; 1.0 g/kg decreased the developments of carr-induced paw edema after 5th hour | [ |
| Acute toxicity, at 10 g/kg | No toxicity observed | |||
| LPS-induced RAW 264.7 cells | No effects on viability; suppressed LPS-induced production of NO, TNF-α, expression of iNOS and COX-2 | |||
| EtOH and H2O-E | Doxorubicin-induced cardiac damage in mice; a daily dose of 30 mg/mL ( | Might regulate NF-kB expression at the transcriptional level; cardiac levels of TBARS, ROS, inflammatory factors, expression of NF-kB; blood pressure ↓; SOD, GPX activity ↑ | [ | |
| EtOH (95% | DMBA-induced hamster buccal pouch carcinogenesis; RMD extracts (50, 100, 200 mg/kg bw, paint for 14 weeks on days alternate to DMBA painting) | Anti-inflammatory and antioxidative activity. Inhibit the pro-inflammatory cytokines TNF-R, IL-1β, IL-6, and IFN-γ, which in turn, leads to oxidative stress. | [ | |
|
| EtOH (70%)-E | Anti-osteosarcoma activity | Induced apoptosis in human osteosarcoma cells line U2OS | [ |
| Saponins | MSU-inducted gouty arthritis mice; TS at 100, 300, 900 mg/kg every 24 h for 7 days, orally | TS (dioscin, protodioscin, pseudo protodioscin) might restore production of pro-inflammatory cytokines TNF-α, pro-interleukins IL-1β and IL-8 to the normal conditions, regulating antioxidant capacities and NALP3 inflammasome. | [ | |
| EtOH (80%)-E and diosgenin in 1% carboxyl methyl-cellulose | ISO-induced myocardial ischemia model in rats; diosgenin at 20, 40, 80 mg/kg for 3 days. | Diosgenin protects the myocardium against ischemic insult through increasing enzymatic and nonenzymatic antioxidant levels; decreasing oxidative stress damage; | [ | |
| Dry precipate of saponins | ISO-induced myocardial ischemia model in rats; 150 and 300 mg/kg for 3 days, orally, both before and after ISO injection | SOD, CAT, GPx, total antioxidant capacity (T-AOC) activity ↑; can protect the myocardium against ischemic insult | [ | |
| Dry precipitate of saponins | Rat model; single dose of 160 mg/kg intragastrically | Diosgenin was one of the main metabolites found in plasma and feces. The extract can play an essential role in cardioprotective efficacy. | [ | |
|
| Crude drug with saponins | Potassium oxonate-induced hyperuricemic mice; 60, 300, 600 mg/kg every 24 h for 6 days, before induction | Total saponins (dioscin, protodioscin, pseudo protodioscin) from RDN had uricosuric effect and could enhance urate excretion and reduce the serum urate levels | [ |
| MeOH-E | Antibacterial activity | Effective against | [ | |
| Fresh-cut, | •OH-induced DNA damage | Can protect against DNA damage (IC50 0.098 ± 0.032 mg/mL); provides a theoretical basis for the application of YP in food and drug industry. | [ | |
|
| MeOH-E | Xylene-induced ear edema damage mice; 2 and 6 g/kg, for 5 days; orally | The inflammatory cytokines, TNF-α, IL-6; oxidative stress ↓ | [ |
| MeOH-E | Antimicrobial activity | Effective against | [ | |
| Cold-soaking extract (CYCSE) | HCT-induced rat; CYCSE 60 mg/kg and 80 mg/kg for 10 days | Can stimulate the NO/cGMP pathway and protect against induced erectile dysfunction; may protect testis morphology, increase TM3 cell proliferation and stimulate testosterone secretion. Suppressed TGF-β1 in injured cells. | [ | |
| Precipate of saponins DP-E | ISO-induced myocardial ischemia model in rats; 150 and 300 mg/kg, 3 days; orally | SOD, CAT GPx, total antioxidant capacity (T-AOC) activity ↑; can protect the myocardium against ischemic insult | [ | |
| EtOH and H2O | Doxorubicin-induced cardiac damage in mice; a daily dose of 30 mg/mL ( | SOD and GPx activity ↑; might regulate NF-kB expression at the transcriptional level; blood pressure, the cardiac levels of TBARS, ROS, and inflammatory factors, the expression of NF kappa B↓. | [ | |
| MeOH | Antibacterial activity using disc diffusion assay | Effective against | [ | |
| MeOH | Antimicrobial activity | Effective against | [ | |
|
| MeOH | Antimicrobial activity | Effective against | [ |
| Total steroid saponins (TSS) | Adjuvant-induced arthritis (AIA) rat; 50, 100, and 200 mg/kg 1/day, every 3 days, respectively, from day 0 to day 28, orally | The levels of pro-inflammatory cytokines IL-1, IL-1β, IL-6, IL-10, and TNF-α ↓; suppressed production of oxidant stress makers: NO, MDA; could protect an injured ankle joint from further deterioration. | [ | |
| LPS-induced RAW | TSS suppresses NF-κB activation by inhibiting the phosphorylation of p65 and IκBα | |||
| MeOH | Mouse fibroblast L929 cell line | No cytotoxic effect. Scratch assay: expression of Collagen-1; induction of migration of fibroblasts to the wound site ↑. | [ |
Abbreviations: AA—ascorbic acid; AIA—adjuvant-induced arthritis; BDB—bark of D. batatas DECNE; cGMP—cyclic 3′,5′-monophosphate; COX-2—cyclooxygenase-2; CYCSE—Chinese yam cold-soaking extract; DACNs—anthocyanins; DP-E—D. panthaica extract; DMBA—7,12-dimethylbenz-[a]anthracene; DMSO—Dimethyl sulfoxide; E—extract; EA—ethyl acetate; EtOH—ethanol; GI—glycemic index; GSH—reduced glutathione; H2O2—hydrogen peroxide; HbAlc—glycated hemoglobin; HCT—hydrocortisone; IBD—inflammatory bowel disease; IFN-γ—interferon-gamma; (IL)-8—interleukin; iNOS—inducible nitric oxide synthase; ISO— isoprenaline; LPS—lipopolysaccharide; MDA—malondialdehyde; MeOH—methanol; NF kappa B—nuclear factor kappa B; NF-κB—nuclear factor-κB; NO—nitric oxide; Nrf2—nuclear factor-erythroid 2-related factor 2; PGE2—prostaglandin E2; RDN—rhizoma D. nipponica; RMD—red mold dioscorea; ROS—reactive oxygen species; SNP—sodium nitroprusside; SOD—superoxide dismutase; STZ—streptozotocin; TBARS—thiobarbituric acid-reacting substances; TGF-β1—transforming growth factor-β1; tGSH—total glutathione; TNBS—trinitrobenzenesulfonic acid; TNF-a—tumor necrosis factor-a; TS—total saponins; TSS—total steroid saponins; YP—yellow powder.
Phytochemicals in Dioscorea spp.
| Species: Plant Part | Solvents | Compounds | Ref. |
|---|---|---|---|
| MeOH | Vitamins (mg/g): male: C, 13.49 ± 3.64; B1, 1.14 ± 0.16; B2, 1.75 ± 0.26; female: C, 18.26 ± 1.37; B1, 1.26 ± 0.11; B2, 1.87 ± 0.2 | [ | |
| EtOH (50%) with 0.1% HCl | Anthocyanins: alatanin C (cyanidin 3-(6-sinapoyl gentiobioside); cyanidin-3-diglucoside; cyanidin-3,5-diglucoside; alatanins B, C; alatanin E, D, F isomers | [ | |
| EtOH (80%) | Phenolic acids (mg/100 g mdw): galic 0.482 ± 0.057; 4-hydroxy benzoic 0.192 ± 0.0024; syringic 0.899 ± 0.0022; sinapic 0.202 ± 0.0501; chlorogenic 0.451 ± 0.0038; ferulic 0.089 ± 0.0005. Flavonoids (mg/100 g mdw): quercetin 0.687 ± 0.0030, apigenin 0.210 ± 0.0041; kaempferol 9.219 ± 0.0043 | [ | |
| mg/100 gm: C, 23.49 ± 0.0413; H2O-soluble B, 0.036 to 4.159 | [ | ||
| MeOH (50%) with 0.1% HCl | Anthocyanins (% peak area): cyanidin-3,5-diglucoside (31.22); cyanidin-3-diglucoside-5-celery glycosides (28.77); delphinidin-3-glucose-5-rutinoside (16.36); delphinidin-3-glucoside (12.18), delphinidin-3,5-diglucoside (11.31) | [ | |
| MeOH (70%) | Phenolic acids (mg/g dw): galic 29.34; 4-hydroxy benzoic 6.48; syringic 2.94; p-coumaric 2.53; myricetin 42.39 | [ | |
| MeOH | Myricetin, gallic acid, ellagic acid, vanillic acid, syringic acid, epicatechin, vanillin, | [ | |
| EtOH (95%) | Phenanthrenes (mg/100 g dw): peel: 2,7-dihydroxy-4,6-dimethoxy 47.35 ± 0.25; 6,7-dihydroxy-2,4-dimethoxy 29.29 ± 0.08; 6-hydroxy-2,4,7-trimethoxy (batatasin I) 35.85 ± 0.12 | [ | |
| Thermally treated meals | Vitamins (mg/100 g): E, 8.3; C, 3.5; B1, 2.1, B2, 0.03 | [ | |
| MeOH | Phenolic acids (µg/g dw). Flesh: gallic 1.69 ± 0.13, isovanillic 1.02 ± 0.06, protocatechuic 0.15 ± 0.01. Peel: gallic 2.30 ± 0.20, isovanillic 0.18 ± 0.02, protocatechuic 0.10 ± 0.02 | [ | |
| EA | Phenolic acids (µg/g dw). Flesh: gallic 0.32 ± 0.14, isovanillic 1.71 ± 0.05, protocatechuic 0.13 ± 0.007. Peel: gallic 0.27 ± 0.03, isovanillic 0.22 ± 0.09, protocatechuic 0.20 ± 0.07 | ||
| DE extract fraction | Total triterpenoids (including esters) (mg/g d.w.): Tokyo 734.71; Kanagawa 716.55 | [ | |
| DE | Total of triterpenoids (including esters) (mg/g dw): 1492.56 | [ | |
| DE extract fraction | Total of triterpenoids (including esters) (mg/g dw): 704.11 | [ | |
| DE extract fraction | Total of triterpenoids (including esters) (mg/g dw): 467.29 | [ | |
| DE extract fraction | Total of triterpenoids (including esters) (mg/g dw): 628.54 | [ | |
| DE extract fraction | Total of triterpenoids (including esters) (mg/g dw): 837.83 | [ | |
| MeOH | Vitamins (mg/g): male: ascorbic acid 10.31 ± 2.75, thiamine 1.15 ± 0.09, riboflavin 0.82 ± 0.07; female: ascorbic acid 12.7 ± 3.64, thiamine 1.03 ± 0.16, riboflavin 0.98 ± 0.12 | [ | |
| MeOH; HPLC | Phenolic acids (µg/g d.w): gallic 6.24 ± 0.07; protocatechuic 0.65 ± 0.02; chlorogenic 0.93 ± 0.03; syringic 26.26 ± 0.42; p-coumaric 0.96 ± 0.05 | [ | |
| MeOH | Phenolic acids (µg/g dw): gallic 0.34 ± 0.00/0.73 ± 0.35, isovanillic 0.28 ± 0.04/0.30 ± 0.06, protocatechuic 0.13 ± 0.02/0.13 ± 0.03. | [ | |
| EA | Phenolic acids (µg/g dw): gallic 0.19 ± 0.03/0.24 ± 0.04, isovanillic 0.88 ± 0.03/0.93 ± 0.09, protocatechuic 0.42 ± 0.02/0.20 ± 0.02. | ||
| NADES containing 30% H2O | Steroidal saponins (%): protodioscin 79.90, protogracillin 68.12, pseudoprotodioscin 67.27, pseudoprotogracillin 74.8 | [ | |
| EtOH (70%) | Saponins (mg/g): protodioscin 159.983 ± 0.064; protogracillin 4.250 ± 0.024; pseudoprotodioscin 13.821 ± 0.037; dioscin 22.999 ± 0.121 | [ | |
| Hot H2O | Phenolic acids (μg/g): gallic 3.56 ± 0.13; chlorogenic 6.77 ± 0.06; vanillic 8.49 ± 0.36; syringic 2.95 ± 0.14; p-coumaric 16.90 ± 0.17. | [ | |
| EtOH (80%) | Phenolic acids (μg/g): gallic 3.10 ± 0.4; chlorogenic 7.92 ± 0.42; vanillic 12.59 ± 0.51; syringic 6.78 ± 0.46; p-coumaric 16.39 ± 0.37 | ||
| AC (50%) → DCM | Norsesquiterpenoids: dioscopposin A, dioscopposin B | [ | |
| MeOH | Phenolic acids (μg/g dw): gallic 3.67 ± 0.10; protocatechuic 0.69 ± 0.02; chlorogenic 1.20 ± 0.04; vanillic 2.08 ± 0.05; syringic 37.35 ± 0.49; p-coumaric 1.65 ± 0.04. | [ | |
| EtOH (70%) | Steroidal saponins (mg/g): protodioscin 3.496 ± 0.018, protogracillin 5.945 ± 0.020, pseudoprotodioscin ND., | [ | |
| MeOH | Gallic acid, rutin, quercetin | [ | |
| MeOH (70%) | Dehydroepiandrosterone, allantoin, 5-hydroxy-7-methoxyflavanone, arnebinone, dioscin, protodioscin | [ | |
| MeOH | Vitamin content (mg/g): male: ascorbic acid 14.29 ± 2.38, thiamine 0.85 ± 0.07, riboflavin 1.02 ± 0.08; female: ascorbic acid 15.88 ± 1.37, thiamine 0.99 ± 0.11, riboflavin 0.94 ± 0.14 | [ | |
| EtOH (75%) | Phenanthropyran: dioscorone B, phenanthrene: 2,2′,6,6′-tetramethoxy-4,4′7,7′-tetrahydroxy-1,1′-biphenanthrenes | [ | |
| EtOH (70%) | Steroidal saponins (mg/g): protodioscin 8.959 ± 0.014, protogracillin 9.902 ± 0.061, pseudoprotodioscin ND, dioscin 9.822 ± 0.014, gracillin 7.123 ± 0.031 | [ | |
| MeOH | Vitamins (mg/g): male: ascorbic acid 9.52 ± 2.38, thiamine 1.25 ± 0.13, riboflavin 1.18 ± 0.1; female: ascorbic acid 12.7 ± 1.4, thiamine 1.11 ± 0.12, riboflavin 1.13 ± 0.24 | [ | |
| Purified from EtOH (80%) E with EA, Sephadex LH-20, and ODS | C22 ω-hydroxy fatty acid, 3-hydroxy-5-methoxybenzoic acid, various phenanthrene derivatives and flavonoids | [ | |
| Pelargonidin, cyanidin, peonidin glycosides and other derivatives | [ | ||
|
| Aromatic benzyl compounds, dihydrostilbenes, phenanthrenes: diarylheptanoids, apigenin | [ | |
| EtOH | 6,7-dihydroxy-2-methoxy-1,4-phenanthrenedione; chrysoeriol 4′- | [ | |
|
| Herorensol, 2,3,4-trimethoxy-7,8-methylenedioxyphenanthrene, 2,4-dimethoxy-7,8-methylendioxy-3-phenanthrenol, chrysotoxene, 2,4,8-trimethoxy-3,7-phenanthrenediol, orchinol, and lusianthridin 7 | [ | |
| MeOH (60%) | µg/100 g: α-Toc 538.66/275.11/554.86; lutein: 18.06/16.35/18.22; zeaxanthin: 11.62/6.70/11.68; β-kryptoxanthin: 2.37/6.12/2.39; β-carotene: 212.23/197.04/212.98; β-carotene: 560.94/462.30/562.91; lycopene: 0.83/0.84/0.84; | [ | |
| (mg/100 g dw) Chlorophyll a/b: 0.43 ± 0.01/0.75 ± 0.02; lycopene 0.30 ± 0.00; phytic acid 1.04 ± 0.42 | [ |
Abbreviations: AC—acetone; C—vitamin C; DCM—dichloromethane; DE—diethyl ether; dw—dry weight; EA—ethyl acetate; EtOH—ethanol; FW—fresh weight; HCl—hydrochloric acid; MeOH—methanol; NADES—natural deep eutectic solvent; ND—not detected; α-Toc—α-tocopherol.
Figure 1The structures of the main important Dioscorea secondary metabolites.